CO
Global Cord Blood Corp
$2.99
Earnings Summary
Revenue | $297.21Mn |
Net Profits | $104.72Mn |
Net Profit Margins | 35.23% |
PE Ratio | 5.24 |
Highlights
Global Cord Blood Corp’s revenue fell -1.69% since last year same period to $297.21Mn in the Q1 2022. On a quarterly growth basis, Global Cord Blood Corp has generated -6.3% fall in its revenue since last 3-months.
Global Cord Blood Corp’s net profit fell -18.02% since last year same period to $104.72Mn in the Q1 2022. On a quarterly growth basis, Global Cord Blood Corp has generated -21.97% fall in its net profits since last 3-months.
Global Cord Blood Corp’s net profit margin fell -16.61% since last year same period to 35.23% in the Q1 2022. On a quarterly growth basis, Global Cord Blood Corp has generated -16.72% fall in its net profit margins since last 3-months.
Global Cord Blood Corp’s price-to-earnings ratio after this Q1 2022 earnings stands at 5.24.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Global Cord Blood Corp post its latest quarter earnings
EPS Estimate Current Quarter | 0 |
EPS Estimate Current Year | 0 |
Highlights
Global Cord Blood Corp’s earning per share (EPS) estimates for the current quarter stand at 0 - a -100% fall from last quarter’s estimates.
Global Cord Blood Corp’s earning per share (EPS) estimates for the current year stand at 0.
Key Ratios
Key ratios of the Global Cord Blood Corp post its Q2 2022 earnings
Earning Per Share (EPS) | 0.04 |
Highlights
Global Cord Blood Corp’s earning per share (EPS) jumped 0% since last year same period to 0.04 in the Q2 2022. This indicates that the Global Cord Blood Corp has generated 0% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2020-04-27 | 0 | 0.04 | +Inf% |
₹0 US Stocks a/c Opening Fee